Other

Granted (in shares)

Year-over-year, this metric grew by 10.4%, from 251K to 277K. Over 4 years (FY 2021 to FY 2025), Granted (in shares) shows relatively stable performance with a -0.7% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026Apr 28, 2026

How to read this metric

Higher grant volumes indicate more aggressive equity-based incentive programs, which may lead to increased future dilution.

Detailed definition

This metric tracks the total number of shares granted to employees and directors under various share-based compensation...

Peer comparison

Commonly disclosed in the equity compensation or stock plan footnotes of annual reports.

Metric ID: other_share_based_compensation_arrangement_by_share_base_1fbc5c

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value2K3K0306K0017K227K1.9M00177K0033K251K2K2K0277K
QoQ Change+50.0%-100.0%-100.0%>999%+748.5%-100.0%-100.0%+660.6%-99.2%+0.0%-100.0%
YoY Change-100.0%-100.0%-25.8%-100.0%-22.0%-100.0%+41.8%-100.0%+10.4%
Range01.9M
CAGR+182.4%
Avg YoY Growth-55.1%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Xylem's granted (in shares)?
Xylem (XYL) reported granted (in shares) of 277K in Q1 2026.
How has Xylem's granted (in shares) changed year-over-year?
Xylem's granted (in shares) increased by 10.4% year-over-year, from 251K to 277K.
What is the long-term trend for Xylem's granted (in shares)?
Over 4 years (2021 to 2025), Xylem's granted (in shares) has grown at a -0.7% compound annual growth rate (CAGR), from 262K to 255K.
What does granted (in shares) mean?
The total volume of shares awarded to employees as part of compensation packages during the period.